Sign in

CIK 0001534248 · Non-accelerated filer<br>Smaller reporting company

Chemomab Therapeutics Ltd.

Sign in to watch
Ticker
CMMB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
operating
EIN
813676773
Phone
972-77-331-0156
Business address
KIRYAT ATIDIM, BUILDING 7, TEL AVIV, Israel
Former names
Anchiano Therapeutics Ltd., BioCancell Ltd.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,516
in 1 filing

Net −$6,516. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Cohen Neil Harris −$7K Director sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2021-03-16 OrbiMed Israel GP Ltd. 10% owner Grant or award · Warrants (Right to Buy) +28,817 28,817
2020-07-16 Cohen Neil Harris Director Grant or award · Stock option (right to buy American Depositary Shares) +172 172
2020-07-16 Polovets Stanislav Director Grant or award · Stock Option (right to buy) +55,000 55,000
2020-07-16 Cohen Neil Harris interim CEO Grant or award · Stock Option (right to buy) +55,000 55,000
2018-03-15 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +131,698 131,698
2018-03-15 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +131,698 131,698
2016-10-28 Darvish Nissim Director Grant or award · Option to Purchase American Depositary Shares +10,123 10,123
2016-10-28 Darvish Nissim Director Grant or award · Option to Purchase American Depositary Shares +10,123 10,123
2016-10-28 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +33,725 33,725
2016-10-28 Mor George Adi Chief Scientific Officer Grant or award · Option to Purchase American Depositary Shares +33,725 33,725

Page 6 of 6 · 110 trades